Activity of Eravacycline Against Carbapenem-resistant Enterobacteriaceae

Grants and Contracts Details

StatusFinished
Effective start/end date11/26/186/30/20

Funding

  • Tetraphase Pharmaceuticals Incorporated: $13,020.00